Trial Information

Summary: A Pilot Study of Safety and Feasibility of Stem Cell Therapy for Aids Lymphoma Using Stem Cells Treated with a Lentivirus Vector-Encoding Multiple Anti-HIV RNAs

You have been asked to participate in this research study because you have AIDS and because you also have a lymphoma.  The purpose of this study is to determine whether genes that inhibit (slow down or stop) HIV in laboratory studies can be put into previously harvested hematopoietic stem cells (immature cells that can become blood cells) and whether these cells can then be transplanted back as part of lymphoma treatment.  Another objective is to evaluate the safety of this procedure. Your treatment on this study will last approximately two months.  After your treatment on this study is over, your medical condition will be followed as part of this research for up to 15 years. 

Patient Inclusion/Exclusion Criteria:

- See http://clinicaltrials.coh.org for additional information.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 2, 2008 at 2:51:06 PM